UniPharma Co., Ltd. Stock Price

TPEX:6621 Community·NT$426.0m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6621 Share Price Performance

NT$12.00

-2.75 (-18.64%)

NT$12.00

-2.75 (-18.64%)

NT$12.00

Mon, 16 Feb 26

Share Pricen/a

6621 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks

0 Rewards

View Full Analysis

UniPharma Co., Ltd. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -1.09
: 52.38%
: -42.78%
: 0%

View Full Analysis

About 6621

Founded: 1998
Employees: 31
CEO: Yu-Shan Wang
WebsiteView website: www.uni-pharma.com

UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan. It provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. The company offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa DR-70 test for in-vitro diagnostics of tumors; and fomeject antidote injection, as well as drug development, research and development, clinical trials, marketing, and other business services. It serves medical centers, regional and area hospitals, and clinics. UniPharma Co., Ltd. was founded in 1998 and is based in Taipei, Taiwan.